P051 Real-world experience of change in lung clearance index (LCI2.5) following initiation of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis aged 6 through 11
| Autor: | Dowle, H., Gilchrist, T., Moffat, K., Forster, J., Macleod, K.A., Urquhart, D.S. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S78-S79 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect